Stockscreener 앱 받기
1.65
1.20%
-0.02
시간 외 거래:
1.65
전일 마감가:
$1.67
열려 있는:
$1.71
하루 거래량:
102.23K
Relative Volume:
0.39
시가총액:
$164.88M
수익:
$17.85M
순이익/손실:
$-96.93M
주가수익비율:
-0.6671
EPS:
-2.4735
순현금흐름:
$-88.29M
1주 성능:
+5.10%
1개월 성능:
-44.63%
6개월 성능:
-65.26%
1년 성능:
-77.91%
1일 변동 폭
$1.61
$1.71
1주일 범위
$1.53
$1.71
52주 변동 폭
$1.26
$8.5878
Nyxoah Sa Stock (NYXH) Company Profile
Compare NYXH vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
1.65 | 166.88M | 17.85M | -96.93M | -88.29M | -2.4735 |
ISRG
Intuitive Surgical Inc
|
405.97 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.19 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.61 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.61 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
198.43 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-31 | 개시 | H.C. Wainwright | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2022-04-21 | 개시 | Oppenheimer | Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2021-12-21 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-07-28 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Nyxoah Sa 주식(NYXH)의 최신 뉴스
Enterprise value to revenue forward of Nyxoah SA – EURONEXT:NYXH - TradingView
Nyxoah sees Orin Hirchman cross 10% voting rights threshold, Resmed drops below 3%. - Pluang
Nyxoah gets two ownership notices: AIGH at 14.55%, Resmed at 1.95% - Stock Titan
Price to earnings forward of Nyxoah SA – LSX:A2QCWK - TradingView
Price to sales forward of Nyxoah SA – LSX:A2QCWK - TradingView
Nyxoah SA Actuals & Estimates (EURONEXT:NYXH) - TradingView
NYXH Forecast — Price Target — Prediction for 2027 - TradingView
Nyxoah to Host Investor Day in New York on July 8, 2026 - Sahm
Nyxoah SA (NYXH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital Concerns - Yahoo Finance
Form 6K Nyxoah For: 23 June By Investing.com - Investing.com Nigeria
Nyxoah (NASDAQ: NYXH) adds $15M EIB debt and details major holders - Stock Titan
Nyxoah SA (NYXH) may report negative earnings: Know the trend ahead of next week's release - MSN
symbol__ Stock Quote Price and Forecast - CNN
Form 13G NYXOAH SA For: 22 June By Investing.com - Investing.com Australia
Form 13G NYXOAH SA For: 22 June - Investing.com UK
AIGH entities and Orin Hirschman report 14.5% stake in NYXOAH (NASDAQ: NYXH) - Stock Titan
Nyxoah SA (NYXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stifel Maintains Nyxoah SA(NYXH.US) With Hold Rating, Maintains Target Price $3 - Moomoo
Nyxoah (NYXH) 44th Annual J.P. Morgan Healthcare Conference Summary - Quartr
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026 - GlobeNewswire
Nyxoah seeks shareholder approval to renew capital authority July 9 - Stock Titan
Nyxoah SA (NYXH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nyxoah SA (NYXH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nyxoah SA (NYXH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nyxoah SA (NYXH) Institutional Confidence - TradingKey
Nyxoah Receives $15 Million From European Investment Bank - Moomoo
Publication relating to transparency notifications - Yahoo Finance UK
Nyxoah Receives $15 Million from the European Investment Bank - Yahoo Finance UK
Stifel cuts Nyxoah stock price target to $3 on capital concerns By Investing.com - Investing.com South Africa
Stifel cuts Nyxoah stock price target to $3 on capital concerns - Investing.com
Nyxoah SA (NYXH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nyxoah SA (NYXH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nyxoah SA (NYXH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
United StatesMintz Advises On Nyxoah’s $95 Million Public Offering - Mondaq
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology - GlobeNewswire
Nyxoah Updates Capital Structure After Major Share Issuance - The Globe and Mail
Nyxoah (NASDAQ: NYXH) adds 55,232,558 new shares after US offering - Stock Titan
Cochlear (NYXH) reports 5.91% beneficial ownership in Nyxoah - Stock Titan
Nyxoah closes underwritten public offering - Medical Buyer
Nyxoah Raises $95 Million Through Public Stock Offering in the United States - Idéal Investisseur
Nyxoah Finalizes Capital Raise - marketscreener.com
Nyxoah Set to Receive $110 Million in New Capital Following Equity Financing, Loan - marketscreener.com
Nyxoah issues 55.2M new shares after US public offering, raising total voting shares to nearly 100M. - Pluang
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch - Sahm
Nyxoah issues 55.2M new shares, boosting total voting rights to nearly 100M. - Pluang
Nyxoah raises $110 million to fund U.S. expansion of sleep apnea device By Investing.com - Investing.com South Africa
Information on the total number of voting rights and shares - GlobeNewswire
Nyxoah raises $110 million to fund U.S. expansion of sleep apnea device - Investing.com
Nyxoah Sa (NYXH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
0.52%
자본화:
|
볼륨(24시간):